COM:NUMINUS
Numinus Wellness Inc.
- Stock
Last Close
0.05
22/11 20:15
Market Cap
12.82M
Beta: -
Volume Today
349.40K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Aug '19 | Aug '20 | Aug '21 | Aug '22 | Aug '23 | ||
---|---|---|---|---|---|---|
average inventory | 3.25K - | 1.62K 50.22% | 1.62K 0% | |||
average payables | 1.43M - | 1.52M 5.95% | 2.01M 32.27% | 2.80M 39.43% | ||
average receivables | 335.40K - | 528.65K 57.62% | 1.06M 100.27% | 1.94M 83.52% | ||
book value per share | 0.02 - | 0.04 131.47% | 0.37 740.65% | 0.19 48.40% | 0.05 72.00% | |
capex per share | -0.01 - | -0.00 95.45% | -0.00 605.56% | -0.01 47.85% | -0.00 75.25% | |
capex to depreciation | -1.62 - | -0.06 96.46% | -0.90 1,460.25% | -0.83 7.55% | -0.13 84.00% | |
capex to operating cash flow | 0.23 - | 0.01 97.17% | 0.04 526.94% | 0.05 15.31% | 0.02 65.28% | |
capex to revenue | -8.14 - | -0.04 99.51% | -0.42 961.66% | -0.19 54.75% | -0.02 91.56% | |
cash per share | 0.00 - | 0.03 1,952.33% | 0.36 1,303.16% | 0.15 57.56% | 0.03 78.67% | |
days of inventory on hand | 6.58 - | 0.74 - | ||||
days payables outstanding | 1.15K - | 796.36 30.72% | 298.38 62.53% | 209.67 29.73% | 71.15 66.07% | |
days sales outstanding | 438.98 - | 224.31 48.90% | 124.37 44.56% | 90.02 27.62% | 35.97 60.05% | |
debt to assets | 0.08 - | 0.08 3.13% | 0.03 69.60% | 0.15 496.23% | 0.30 98.36% | |
debt to equity | 0.18 - | 0.15 16.26% | 0.03 82.48% | 0.19 622.07% | 0.51 169.03% | |
dividend yield | ||||||
earnings yield | -0.10 - | -0.64 553.96% | -0.13 79.08% | -0.58 329.86% | -0.59 2.25% | |
enterprise value | 74.41M - | 13.79M 81.47% | 82.51M 498.33% | 52.78M 36.04% | 50.03M 5.21% | |
enterprise value over ebitda | -12.67 - | -2.09 83.47% | -5.44 160.00% | -1.99 63.41% | -2.03 1.91% | |
ev to operating cash flow | -19.79 - | -2.57 86.99% | -5.30 105.69% | -2.01 62.01% | -2.20 9.24% | |
ev to sales | 692.29 - | 15.65 97.74% | 54.51 248.32% | 8.13 85.09% | 2.16 73.44% | |
free cash flow per share | -0.06 - | -0.08 31.38% | -0.10 16.41% | -0.13 29.00% | -0.09 30.82% | |
free cash flow yield | -0.06 - | -0.36 475.84% | -0.12 67.82% | -0.35 204.58% | -0.45 27.71% | |
graham net net | -0.02 - | -0.00 79.01% | 0.34 7,804.41% | 0.11 69.16% | 0.00 99.97% | |
graham number | 0.21 - | 0.39 85.84% | 0.97 152.19% | 0.94 3.08% | 0.37 60.62% | |
income quality | 0.52 - | 0.56 7.82% | 0.83 48.75% | 0.58 29.57% | 0.75 28.72% | |
intangibles to total assets | 0 - | 0 | 0 | 0.05 Infinity% | 0 100% | |
interest coverage | -124.32 - | -50.70 59.22% | -139.05 174.24% | -50.21 63.89% | -36.17 27.95% | |
interest debt per share | 0.00 - | 0.01 114.82% | 0.01 17.67% | 0.04 272.52% | 0.03 22.23% | |
inventory turnover | 55.45 - | 493.72 - | ||||
invested capital | 0.18 - | 0.15 16.26% | 0.03 82.48% | 0.19 622.07% | 0.51 169.03% | |
market cap | 74.25M - | 15.00M 79.80% | 140.20M 834.92% | 77.97M 44.39% | 51.41M 34.07% | |
net current asset value | -1.41M - | 347.92K 124.67% | 57.66M 16,471.64% | 24.70M 57.15% | 1.77M 92.83% | |
net debt to ebitda | -0.03 - | 0.18 790.39% | 3.81 1,979.12% | 0.95 75.02% | 0.06 94.11% | |
net income per share | -0.10 - | -0.15 49.21% | -0.11 24.35% | -0.21 82.06% | -0.11 44.62% | |
operating cash flow per share | -0.05 - | -0.08 60.88% | -0.09 12.54% | -0.12 28.22% | -0.09 28.71% | |
payables turnover | 0.32 - | 0.46 44.34% | 1.22 166.90% | 1.74 42.31% | 5.13 194.68% | |
receivables turnover | 0.83 - | 1.63 95.70% | 2.93 80.36% | 4.05 38.15% | 10.15 150.30% | |
research and ddevelopement to revenue | 1.38 - | 0.21 84.49% | 0.93 332.75% | 0.29 68.64% | 0.05 82.64% | |
return on tangible assets | -2.36 - | -1.87 20.61% | -0.29 84.38% | -0.90 205.98% | -1.24 38.85% | |
revenue per share | 0.00 - | 0.01 826.19% | 0.01 33.54% | 0.03 226.72% | 0.09 193.25% | |
roe | -5.32 - | -3.43 35.54% | -0.31 91.00% | -1.09 252.86% | -2.15 97.77% | |
roic | -3.83 - | -2.49 34.79% | -0.28 88.59% | -0.49 73.56% | -0.98 98.64% | |
sales general and administrative to revenue | 49.03 - | 6.82 86.09% | 7.72 13.24% | 3.88 49.82% | 1.32 66.02% | |
shareholders equity per share | 0.02 - | 0.04 131.47% | 0.37 740.65% | 0.19 48.40% | 0.05 72.00% | |
stock based compensation to revenue | 18.15 - | 2.13 88.27% | 1.20 43.49% | 0.53 55.79% | 0.08 84.88% | |
tangible asset value | 1.37M - | 2.80M 104.90% | 60.83M 2,072.90% | 38.70M 36.38% | 14.05M 63.70% | |
tangible book value per share | 0.02 - | 0.04 131.47% | 0.37 740.65% | 0.18 51.55% | 0.05 70.18% | |
working capital | -1.31M - | 663.67K 150.64% | 59.06M 8,798.56% | 31.54M 46.60% | 7.41M 76.50% |
All numbers in CAD (except ratios and percentages)